Tevogen Inc. (TVGN) Form 8-K — Nov 2, 2026
Tevogen amended its $36.0 million Loan Agreement with The Patel Family, LLP on October 27, 2026, extending the borrowing window to May 31, 2029 and fixing the share-payment price at $7.40 per share. On November 2, 2026 the Company repaid its entire $7.4 million principal plus $177,880 of accrued interest by issuing 1,000,000 Principal Shares and 23,733 Interest Shares, eliminating all outstanding loan liabilities. Approximately $28.6 million of borrowing capacity remains, and a full draw paid in stock could add roughly 4.99 million shares, subject to a 19.99% issuance cap and a 9.99% lender ownership limit.
Key figures
- Debt Amount
- 7400000
- Interest Rate
- 7
- Maturity Date
- May 31, 2029 (borrowing window extension)
- Offering Price
- $7.40 per share (Share Payment Price for principal/interest shares)
- Shares Offered
- 1,000,000 Principal Shares + 23,733 Interest Shares issued Nov 2, 2026; 50,000,000 Restricted Shares granted to CEO
- Shares Outstanding
- 67880267
- Issuance cap
- 19.99% of shares outstanding on First Amendment Effective Date
- Pipe option size
- $14 million at 70% of Trailing VWAP once VWAP reaches $500.00
- Rsa vesting threshold
- $1.0 billion aggregate revenue by December 31, 2031
- Original facility size
- 36000000
- Accrued interest repaid
- 177880
- Remaining facility capacity
- 28600000
- Saadi voting power after grant
- approximately 90.9%
- Beneficial ownership limitation
- 9.99%
- Potential additional shares full draw
- approximately 4.99 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.